HUBB

Hubbell Incorporated

$403.66

-3.60%
Nov 20, 2026
Bobby Quantitative Model
Hubbell Incorporated is a 138-year-old manufacturer of electrical and utility infrastructure components, operating through an Electrical Solutions segment (~$845M quarterly revenue) serving commercial, industrial, and residential construction markets and a Utility Solutions segment (~$1.03B quarterly revenue) supplying transmission and distribution grid hardware, connectors, and substation equipment — roughly 90% of revenue is generated in the United States. The company is best characterized as a high-quality, brand-dense industrial compounder (75+ brands, #1 or #2 share in most product lines) rather than a disruptor, with its moat built on specification-driven utility relationships, replacement-cycle demand, and pricing power in fragmented niches. The current investor narrative is dominated by the electrification and grid-investment megatrend — data-center load growth, utility capex cycles, and infrastructure spending — which Hubbell has leaned into aggressively with the ~$3 billion acquisition of NSI announced in May 2026, a deal management expects to be accretive to earnings. That strategic bet, however, is now colliding with a sharply deteriorating share price and a Q3 print that, while showing 24.6% revenue growth, revealed margin compression and rising leverage, leaving investors to debate whether Hubbell is a discounted quality compounder or a serial acquirer overpaying at the top of the cycle.

People also watch

Vertiv

Vertiv

VRT

Analysis
Bloom Energy

Bloom Energy

BE

Analysis
Ametek

Ametek

AME

Analysis
Acuity Brands

Acuity Brands

AYI

Analysis
Forgent Power Solutions, Inc.

Forgent Power Solutions, Inc.

FPS

Analysis

BobbyInvestment Opinion: Should I buy HUBB Today?

Rating: Hold with a constructive lean. Hubbell is a high-quality, 75-brand electrical and utility infrastructure compounder whose 24.63% Q3 revenue growth and 23.05% ROE are real, but the ~$3B NSI acquisition has temporarily broken the earnings model — net margin fell to 14.02% from 17.01% and interest coverage compressed from 24.3x to roughly 7.0x — so the stock deserves a Hold until margin stabilization is demonstrated, anchored by the 13-analyst 'buy' consensus (mean 2.0) and a $537.62 average target implying 23.0% upside. The bull case is that the sell-side is right and the decline is overdone; the bear case is that those targets are stale after a 14.55% three-month slide.

The supporting evidence is genuinely two-sided. On valuation, the stock trades at 26.71x trailing but only 18.95x forward earnings — a 29% compression implying roughly 41% EPS growth to the $27.71 consensus 2027 estimate — with a 4.04x PS near the low end of its 7.6x–17.2x 2022–2026 range and a 1.78x PEG that is not stretched. On fundamentals, revenue grew 24.63% YoY to $1.8725B with sequential step-ups from $1.517B to $1.711B to $1.872B, free cash flow is $928M TTM at 7.6x capex coverage, and gross margin actually improved to 36.75% from 36.23%. Against that, net margin fell ~300bps, debt-to-equity rose to 0.678 from 0.526, cash flow-to-debt is just 0.063, and the GAAP EPS of $4.96 versus key-metrics EPS of $0.0375 raises earnings-quality questions. The 23.0% implied upside is offset by the fact that the lowest Street target of $470 is only 7.6% above spot — a thin floor if estimates get cut.

The biggest risks that could invalidate the thesis are (1) NSI integration missteps or slower-than-expected accretion, (2) continued margin dilution from $58.0M quarterly interest expense and $63.4M of other acquisition-related costs, and (3) a break of the $403.82 52-week low that triggers momentum-fund liquidation. This Hold would upgrade to Buy if Q4 operating margin recovers toward the 22.0% level of Q3 2025 and forward EPS of $27.71 holds, or if the stock pulls back toward $400–$410 and the forward PE compresses below 15x; it would downgrade to Sell if organic growth (ex-NSI) turns negative or interest coverage falls below 5x. On balance the stock looks fairly valued to modestly undervalued relative to its own history — trailing PE mid-range, forward PE and PS near historical lows — but the discount is a rational price for execution risk, not a free lunch.

Sign up to view all

HUBB 12-Month Price Forecast

Hubbell presents a classic quality-versus-execution trade-off: the franchise is real (23.05% ROE, $928M TTM free cash flow, 75+ brands with #1 or #2 share) and the forward valuation at 18.95x is undemanding if the $27.71 EPS estimate is achieved, yet the near-term evidence is deteriorating with ~300bps of net margin compression, interest coverage down from 24.3x to roughly 7.0x, and a stock 8.2% off its 52-week low in an accelerating downtrend. The 23.0% implied upside to the average target is compelling on paper, but the persistence of the Neutral camp and the 14.55% three-month decline suggest the Street is waiting for margin evidence rather than leading it. We would upgrade to bullish if Q4 operating margin recovers above 21% and forward EPS estimates hold, and downgrade to bearish if organic growth turns negative or a break of $403.82 confirms the acquisition was struck at the cycle top. With a 0.836 beta offering some cushion but a -24.93% drawdown showing low beta has not protected holders from idiosyncratic de-rating, the risk/reward is balanced rather than compelling at $436.98.

Historical Price
Current Price $403.66
Average Target $504.00
High Target $600.00
Low Target $404.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Hubbell Incorporated's 12-month outlook, with a consensus price target around $537.62 and implied upside of +33.2% versus the current price.

Average Target

$537.62

15 analysts

Implied Upside

+33.2%

vs. current price

Analyst Count

15

covering this stock

Price Range

$470 - $600

Analyst target range

Buy
8 (53%)
Hold
7 (47%)
Sell
0 (0%)

Coverage is solid with 13 analysts, and the distribution is constructive but not euphoric: 8 Buy, 7 Hold, 0 Sell, yielding a consensus recommendation of "buy" with a mean rating of 2.0 on a 1–5 scale. The average target price of $537.62 implies 23.0% upside from the current $436.98 — a meaningful gap that suggests the sell-side views the recent decline as overdone relative to fundamentals. Notably, the lowest target on the Street is $470.00, which is still 7.6% above the current price, meaning not a single covering analyst sees downside from here — a rare unanimity that either signals genuine value or a lagging, stale-target problem given the stock's 14.55% three-month decline.\n\nThe target range of $470 to $600 is wide (a 27.7% spread from low to high), signaling meaningful disagreement about the acquisition's earnings contribution and margin trajectory. The $600 high target implies roughly 37% upside and would require the market to re-rate Hubbell back toward its 2026 highs, assuming successful NSI integration, margin recovery to the 22%+ operating levels of 2025, and continued utility capex tailwinds. The $470 low target prices in a more cautious scenario — modest multiple expansion only, with acquisition-related interest expense and margin dilution persisting. Institutional ratings show a stable-to-cautious pattern: JP Morgan, Wells Fargo, and Morgan Stanley remain Neutral/Equal Weight as of late 2026, while Baird, Evercore ISI, Mizuho, and Stephens maintain Outperform/Overweight — no downgrades, but also no fresh upgrades to catalyze a re-rating, and the persistence of the Neutral camp alongside a 23% implied upside suggests the Street is waiting for evidence of margin stabilization before committing.

Drowning in data?

Find the real signal!

Bulls vs Bears: HUBB Investment Factors

The bear case currently has stronger near-term evidence: margin compression of ~300bps, interest coverage collapsing from 24.3x to ~7.0x, and a relentless downtrend that has the stock 8.2% off its 52-week low with accelerating negative momentum. The bull case rests on valuation and forward estimates — an 18.95x forward PE, a 23% implied upside to the $537.62 average target, and a Street where no analyst sees downside — but those targets may be stale given the 14.55% three-month decline. The single most important tension is whether the NSI acquisition's earnings accretion materializes before the higher interest burden and margin dilution force estimate cuts; if forward EPS of $27.71 holds, the stock is cheap, but if estimates are too high, the 26.71x trailing multiple is the truer picture. Until margin stabilization is demonstrated, the weight of evidence favors caution over the discounted-quality-compounder narrative.

Bullish

  • Analyst targets imply 23% upside: The 13-analyst consensus is 'buy' (mean 2.0) with an average target of $537.62, 23.0% above the $436.98 price. Critically, the lowest target on the Street is $470.00 — still 7.6% above spot — meaning no covering analyst models downside from here.
  • Forward PE of 18.95x is cheap: The stock trades at 26.71x trailing but only 18.95x forward earnings, a 29% compression that implies the market expects roughly 41% EPS growth to the $27.71 consensus 2027 estimate. That forward multiple sits below many grid-exposed electrical equipment peers.
  • Revenue growing 24.6% with utility mix shift: Q3 2026 revenue of $1.8725B grew 24.63% YoY from $1.5024B, with sequential step-ups from $1.517B (Q1) to $1.711B (Q2) to $1.872B (Q3). Utility Solutions at $1.028B is now the larger segment versus Electrical at $845M, confirming the grid/electrification growth engine.
  • Strong cash generation and returns: Free cash flow is $928M TTM and $280.4M in Q3 alone, with operating cash flow of $322.6M against just $42.2M of capex (7.6x coverage). ROE of 23.05% and ROA of 8.53% remain strong for an industrial manufacturer.

Bearish

  • Net margin collapsed ~300bps YoY: Q3 2026 net margin fell to 14.02% from 17.01% a year ago despite gross margin rising to 36.75% from 36.23%. Interest expense ballooned from $13.6M to $58.0M and other expenses hit $63.4M tied to acquisition financing, crushing the bottom line.
  • Leverage and interest coverage deteriorated: Debt-to-equity rose to 0.678 from 0.526 at year-end 2024, funded by $2.80B of debt issuance against $3.008B of acquisition outflows. Interest coverage compressed from 24.3x a year ago to roughly 7.0x, and cash flow-to-debt has fallen to 0.063.
  • Persistent downtrend with -24.93% drawdown: The stock is down 14.55% over three months and 7.69% over one month, underperforming SPY by 11.72 and 5.43 points respectively. At $436.98 it sits just 8.2% above its 52-week low of $403.82 and 22.7% below its $565.50 high, with a textbook sequence of lower highs.
  • Earnings quality discrepancy: GAAP EPS of $4.96 in Q3 masks a reported key-metrics EPS of just $0.0375, a gap that likely reflects adjusted-versus-GAAP treatment of deal costs and warrants scrutiny. If headline earnings quality is deteriorating, the margin story is weaker than the gross-margin line implies.

HUBB Technical Analysis

Hubbell is in a clear, sustained downtrend, with the stock down 0.15% over the trailing year and 5.63% year-to-date, a stark underperformance against a SPY that gained 12.27% over the same twelve months (relative strength of -12.42%). At $436.98, the stock sits at just 20.5% of its 52-week range of $403.82–$565.50 — a positioning that screams falling knife rather than value opportunity, given the price is only 8.2% above its 52-week low and 22.7% below its high. The maximum drawdown of -24.93% confirms a technical bear market, and with the 52-week high set well above current levels, every rally has been sold into.\n\nShort-term momentum is decisively negative and, critically, accelerating to the downside: the stock is down 7.69% over the past month and 14.55% over three months, meaning the 3-month decline is nearly double the 1-year decline — a classic pattern of trend deterioration rather than stabilization. The 1-month relative strength of -5.43% versus SPY's -2.26% shows Hubbell is not merely participating in a soft tape but underperforming it by more than 2x, and the 6-month change of -8.96% versus SPY's +2.13% (a -11.09% relative spread) confirms persistent, structural selling pressure. The recent sequence of lower highs — from the ~$539 June peak to ~$519 in August to ~$485 in October to the current ~$437 — is textbook distribution, and the November 5 close of $418.79 marked a fresh leg lower that has only weakly bounced.\n\nKey technical levels are well defined: support sits at the 52-week low of $403.82, roughly 7.6% below the current price, and a break there would likely trigger momentum-fund liquidation and open a deeper air pocket. Resistance is layered at the $460–$475 zone (the October consolidation shelf) and then the $52-week high of $565.50, which is 29.4% above spot and would require a full trend reversal to reclaim. With a beta of 0.836, Hubbell is roughly 16% less volatile than the market on a historical basis, which argues for larger position sizing tolerance on a risk-adjusted basis — but the -24.93% drawdown shows that low beta has not protected holders from idiosyncratic, acquisition-related de-rating, and the 4.08 short ratio suggests bears are not aggressively pressing but also that there is no short-squeeze catalyst in reserve.

Beta

0.84

0.84x market volatility

Max Drawdown

-27.6%

Largest decline past year

52-Week Range

$402-$565

Price range past year

Annual Return

-0.9%

Cumulative gain past year

PeriodHUBB ReturnS&P 500
1m-12.4%-9.7%
3m-14.1%-9.9%
6m-15.0%-7.5%
1y-0.9%+4.7%
ytd-12.8%+1.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

HUBB Fundamental Analysis

Revenue growth is genuinely strong and accelerating: Q3 2026 revenue of $1.8725B grew 24.63% year-over-year versus $1.5024B in Q3 2025, and the sequential cadence ($1.517B in Q1, $1.711B in Q2, $1.872B in Q3) shows consistent step-ups that imply a roughly $7.3B annualized run-rate. The Utility Solutions segment at $1.028B is now the larger of the two businesses versus Electrical at $845M, confirming that grid/electrification exposure is the growth engine — though a meaningful portion of the 24.6% top-line growth is inorganic, reflecting the NSI acquisition rather than pure organic demand. The investment case therefore hinges on whether Hubbell can sustain mid-single-digit organic growth on top of acquired revenue, and the decelerating price action suggests the market is skeptical that the acquisition math will hold.\n\nProfitability remains solid in absolute terms but is compressing at the margin: Q3 2026 net income of $262.5M on a 14.02% net margin and 36.75% gross margin compares unfavorably to Q3 2025's $255.5M net income on a 17.01% net margin and 36.23% gross margin — net margin fell roughly 300bps year-over-year despite higher gross margin, driven by interest expense ballooning from $13.6M to $58.0M and other expenses of $63.4M tied to the acquisition financing. Operating margin of 21.83% in Q3 is up from 17.39% in Q1 but down from 22.00% a year ago, and the trailing operating margin of 20.83% with a 15.18% net margin remains respectable for electrical equipment manufacturing. The key concern is that GAAP EPS of $4.96 in Q3 masks a reported key-metrics EPS of just $0.0375, a discrepancy that likely reflects adjusted-versus-GAAP treatment of deal costs and warrants scrutiny — if the headline earnings quality is deteriorating, the margin story is weaker than the gross-margin line implies.\n\nThe balance sheet has visibly levered up to fund the NSI deal: debt-to-equity stands at 0.678 (up from 0.526 at year-end 2024), the Q2 2026 cash flow statement shows $3.008B of acquisition outflows funded by $2.80B of debt issuance, and cash fell to $334.5M by Q3 from $501.7M in Q1. Free cash flow remains healthy at $928M TTM and $280.4M in Q3 alone, with operating cash flow of $322.6M against capex of just $42.2M (a 7.6x capex coverage ratio), and ROE of 23.05% and ROA of 8.53% are strong — but the cash flow-to-debt ratio has fallen to 0.063 and interest coverage has compressed from 24.3x a year ago to roughly 7.0x, a meaningful deterioration in financial flexibility. Current ratio of 1.72 provides adequate near-term liquidity, but with $254.4M of debt repaid in Q3 and dividends of $75M per quarter, Hubbell's internal cash generation is now stretched to service a materially larger debt load.

Quarterly Revenue

$1.9B

2026-09

Revenue YoY Growth

+24.6%

YoY Comparison

Gross Margin

36.8%

Latest Quarter

Free Cash Flow

$928000000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Electrical Segment
Utility Solutions Segment

Open an Account, get $2 TSLA now!

Valuation Analysis: Is HUBB Overvalued?

Because Hubbell is solidly profitable (Q3 net income of $262.5M, TTM net margin of 15.18%), the PE ratio is the appropriate primary metric. The stock trades at 26.71x trailing earnings but only 18.95x forward earnings — a 29% compression that implies the market expects roughly 41% EPS growth, consistent with the $27.71 consensus 2027 EPS estimate versus the current run-rate. That forward discount is the bull case in one number: if Hubbell delivers, the stock is cheap; if estimates are too high, the trailing multiple is the truer picture.\n\nAgainst its own sector, Hubbell screens as a premium asset on some measures and a discount on others: the 4.04x PS ratio and 4.25x EV/Sales are elevated for an industrial, but the 18.33x EV/EBITDA is reasonable for a high-quality electrical equipment franchise, and the 1.78x PEG ratio suggests the growth-adjusted multiple is not stretched. The 6.14x price-to-book is rich versus a typical industrial, reflecting Hubbell's asset-light brand portfolio and 23.05% ROE, but the 22.96x price-to-cash-flow and 18.95x forward PE are the more decision-relevant figures. On balance, the valuation embeds a premium for quality and electrification exposure, but the forward PE of 18.95x is below where many grid-exposed peers trade — the discount is the market's skepticism about acquisition integration and margin recovery.\n\nHistorically, Hubbell's PE has ranged from roughly 17.9x (Q1 2023) to 37.9x (Q1 2024), with a median in the low-to-mid 20s; at 26.71x trailing, the stock sits in the upper-middle of that band, not at an extreme. The PS ratio tells a more cautionary story: 4.04x today versus historical quarterly readings that ranged from 7.6x to 17.2x in the 2022–2026 window, meaning the current PS is near the low end of its own history — a signal that either the market has de-rated the revenue base (post-acquisition dilution of the multiple) or that a value opportunity is forming. The honest read is that the trailing PE is mid-range while the forward PE and PS are near historical lows, which is exactly the setup you see when a stock is being priced for execution risk rather than fundamental deterioration.

PE

26.7x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 18x~30x

vs. Industry Avg

27.8x

Industry PE ~27.8x*

EV/EBITDA

18.3x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on the balance sheet transformation from the ~$3B NSI deal. Debt-to-equity has risen to 0.678 from 0.526 at year-end 2024, funded by $2.80B of debt issuance, while interest expense jumped from $13.6M to $58.0M YoY and interest coverage compressed from 24.3x to roughly 7.0x. Net margin fell to 14.02% from 17.01% despite gross margin improving to 36.75%, and the cash flow-to-debt ratio of 0.063 leaves limited flexibility with $75M quarterly dividends and $254.4M of debt repaid in Q3. The GAAP EPS of $4.96 versus key-metrics EPS of $0.0375 also raises earnings-quality questions around deal-cost treatment. Market and competitive risks stem from a valuation that still embeds a quality premium and a technical trend that is deteriorating. At 26.71x trailing earnings and 6.14x book, Hubbell is priced above a typical industrial, and the 4.04x PS — near the low end of its 7.6x–17.2x historical range — signals the market is de-rating the revenue base post-acquisition. Beta of 0.836 offers some downside cushion, but the stock has underperformed SPY by 12.42 points over one year and 16.25 points YTD, and the persistence of the Neutral camp (JP Morgan, Wells Fargo, Morgan Stanley) alongside a 23% implied upside suggests the Street is waiting for margin evidence before committing. The worst-case scenario is a chain of NSI integration missteps, continued margin dilution, and estimate cuts that break the $403.82 52-week low, triggering momentum-fund liquidation into an air pocket. From the current $436.98, a move to the 52-week low represents roughly -7.6%, and a full retracement toward the $470 low analyst target being breached on the downside — combined with the -24.93% max drawdown already realized — implies a realistic adverse outcome of -15% to -25% (roughly $328–$371) if forward EPS estimates of $27.71 prove unreachable.

FAQ

The most severe risk is financial: net margin fell to 14.02% from 17.01% YoY as interest expense jumped from $13.6M to $58.0M, interest coverage compressed from 24.3x to roughly 7.0x, and debt-to-equity rose to 0.678 from 0.526 — a materially larger debt load with cash flow-to-debt at just 0.063. Second is acquisition/execution risk: a meaningful portion of the 24.63% revenue growth is inorganic from the ~$3B NSI deal, and if accretion disappoints, the $27.71 forward EPS estimate and the Street's stale targets both come under pressure. Third is technical/momentum risk: the stock is 8.2% off its $403.82 52-week low with a -24.93% max drawdown and -14.55% three-month decline, so a break of support could force further liquidation. Fourth is valuation-compression risk: at 26.71x trailing and 6.14x book, any de-rating toward industrial norms would hurt even if fundamentals hold, and the persistence of the Neutral camp means no fresh upgrade catalyst is in reserve.

The 12-month forecast splits into three scenarios. The base case (55% probability) targets $470–$538, assuming margins stabilize at a lower plateau, revenue decelerates toward the $8.86B consensus, and the stock grinds back toward the $537.62 average target without a full re-rating. The bull case (25%) targets $565–$600, requiring NSI integration on plan, operating margin recovering toward 22.0%, and utility capex plus data-center load growth sustaining the growth trajectory — the $600 high target implies roughly 37% upside. The bear case (20%) targets $404–$470, with NSI integration stumbles, margin dilution, and estimate cuts breaking the $403.82 52-week low. The base case is most likely, and its key assumption is that forward EPS of $27.71 is broadly achieved, keeping forward PE near 18.95x.

The answer depends on which multiple you weight. On trailing earnings, HUBB at 26.71x sits in the upper-middle of its historical 17.9x–37.9x range — not cheap, not extreme. On forward earnings, 18.95x implies roughly 41% EPS growth to the $27.71 consensus and is below where many grid-exposed electrical equipment peers trade, which is the bull case in one number. The 4.04x PS is near the low end of its 2022–2026 range of 7.6x–17.2x, and the 1.78x PEG suggests the growth-adjusted multiple is not stretched, while the 6.14x price-to-book is rich versus a typical industrial. The market is paying a premium for quality and electrification exposure but a discount for acquisition-integration and margin-recovery risk. On balance the stock looks fairly valued to modestly undervalued relative to its own history, with the discount a rational price for execution risk rather than a free lunch.

From a risk/reward standpoint, HUBB offers a 23.0% implied upside to the $537.62 average analyst target, and notably the lowest Street target of $470.00 sits 7.6% above the current $436.98 — meaning no covering analyst models downside. The forward PE of 18.95x is undemanding if the $27.71 consensus EPS is achieved, and the 4.04x PS sits near the low end of its 7.6x–17.2x historical range. Against that, the biggest downside risk is a break of the $403.82 52-week low, which would represent roughly -7.6% from spot and could trigger momentum-fund liquidation toward the -15% to -25% adverse range. The stock is a reasonable buy for long-horizon, quality-oriented investors who believe NSI accretion materializes and margins stabilize, but it is not a compelling buy for momentum or short-term traders given the accelerating downtrend. A staged entry or waiting for Q4 margin evidence above 21% would improve the risk/reward.

HUBB is better suited to long-term holding than short-term trading. The franchise is a 138-year-old, 75-brand compounder with 23.05% ROE, $928M TTM free cash flow, and structural exposure to electrification and grid investment — the kind of durable earnings stream that rewards patience. The beta of 0.836 makes it roughly 16% less volatile than the market, which supports a core holding role, but the -24.93% max drawdown shows low beta has not protected holders from idiosyncratic, acquisition-related de-rating. Short-term traders face an accelerating downtrend (-14.55% over three months, -7.69% over one month) and a thin 1.21% dividend yield that offers little carry while waiting. A concrete suggested minimum holding period is 12–24 months, long enough for NSI costs to annualize out and for margin recovery to be demonstrated, with a staged entry rather than a single lump sum given the technical setup.